Natco Pharma plans to launch Molnupiravir capsules this week
The company has received approval for Molnupiravir capsules (200 mg), which would be sold under brand name Molnunat in the country
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.